Comparison of clinical outcomes of hypertensive patients between ARBs/ACE inhibitors and non-ARBs/ACE inhibitors
| Hypertension (n=220) | ARBs/ACE inhibitors (n=53) | Non-ARBs/ACE inhibitors (n=167) | P value | |
| Age, years | 67 (58–76) | 67 (59–73) | 68 (58–77) | 0.648 |
| Gender, male | 106 (48.4%) | 28 (52.8%) | 78 (47.0%) | 0.459 |
| ICU during stay | 28 (12.7%) | 3 (1.4%) | 25 (11.4%) | 0.076 |
| Mortality | 16 (7.3%) | 2 (3.8%) | 14 (8.4%) | 0.260 |
| Hospitalisation time (days) | 14 (9–22) | 14 (11–21) | 14 (9–22) | 0.643 |
ARBs, angiotensin II receptor blockers; ICU, intensive care unit.